Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.240
+0.040 (1.25%)
Nov 4, 2025, 4:00 PM EST - Market closed
Apyx Medical Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Apyx Medical in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Apyx Medical.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +54.32% | Nov 10, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +38.89% | Aug 11, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +146.91% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
51.00M
from 48.10M
Increased by 6.03%
Revenue Next Year
53.54M
from 51.00M
Increased by 4.97%
EPS This Year
-0.37
from -0.66
EPS Next Year
-0.43
from -0.37
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 52.5M | 55.2M | |||
| Avg | 51.0M | 53.5M | |||
| Low | 49.0M | 51.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.2% | 8.2% | |||
| Avg | 6.0% | 5.0% | |||
| Low | 1.9% | 0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.35 | -0.42 | |
| Avg | -0.37 | -0.43 | |
| Low | -0.41 | -0.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.